Information, Symptoms, Treatments and Resources

MRI Protocol for the Diagnosis and Follow-up of MS
visit the
MS Information Index
  visit the
MS Community
Information Index MS 
Community Information & Resourses

Consortium of MS Centers  
MRI Protocol for the Diagnosis and Follow-up of MS

Anthony Traboulsee, MD; David Li, MD; Joseph Frank, MD;
Jack Simon, MD; Patricia Coyle, MD; Jerry Wolinsky, MD; Donald Paty, MD

June 2003

I. CLINICAL GUIDELINES for Brain and Spinal Cord MRI in MS

Suspected MS:

Baseline evaluation:
• Brain MRI recommended (with gadolinium)
• Spinal Cord MRI if presenting symptoms are at the level of the spinal cord and have not
resolved, or if the Brain MRI is non-diagnostic.

Follow-up evaluation:
• Brain MRI recommended to demonstrate new disease activity

Established MS indications:

Baseline evaluation:
• Brain MRI recommended (gadolinium optional)

Follow-up of MS:
• Unexpected clinical worsening
• Re-assessment of disease burden before starting or modifying therapy
• Suspicion of a secondary diagnosis

II. MRI PROTOCOLS for Brain and Spinal Cord

Field Strength: 1.0 Tesla or higher recommended for brain or spinal cord.
(Note: 1T open ring magnets have an effective field strength of approximately 0.7 Tesla and are
only recommended when patients can not tolerate the closed magnet).

Slice Thickness: < 3mm and no gap and in plane resolution of < 1mm x 1 mm for both Brain and spinal cord. (Note: < 5mm and no gap is acceptable for Brain MRI for centers that are unable to acquire 3mm slices in the allotted time).

Scan Orientation and Coverage:
Reproducible coverage and orientation for the axial slices using the subcallosal line as a reference on an appropriate Sagittal localizer is critical for longitudinal comparisons.

Brain MRI Sequences:
1st: Sagittal FLAIR (fluid attenuating inversion recovery).
2nd: Axial PD/T2 (proton density and T2 weighted T1 usually  80ms)
3rd: Axial FLAIR
4th: Gadolinium enhanced T1 (if suspicious lesions seen on FLAIR).
Note: all 4 sequences recommended for a diagnostic MRI in suspected MS. The Sagittal FLAIR and gadolinium enhanced T1 are optional in the follow-up study for established MS.

Spinal Cord Sequences:
1st: Sagittal PD/T2
2nd: Sagittal pre-Gad T1
3rd: Sagittal post-Gad T1
4th: Axial post-Gad T1 through suspicious lesions.
5th: Axial T2 through suspicious lesions.

• The recommended dose is 0.1 mmol/kg IV
• The minimum delay after giving gadolinium is 5 minutes before acquiring the axial T1 weighted axial post contrast images.
• Gadolinium does not need to be given for a spinal cord MRI if it follows a contrast Brain MRI study.

Time saving strategies:
• Omit the axial Fast Spin Echo PD
• Only cover the corpus callosum with the Sagittal FLAIR.
• Acquire the axial FLAIR after giving gadolinium and before the axial T1 weighted axial post contrast images.

The report should use common language and be descriptive including:
• Lesion number, location, size, shape, character and a qualitative assessment of brain atrophy.
• Comparison with previous studies for new, enlarging and/or enhancing lesions and atrophy.
• Interpretation and differential diagnosis.

An optional standardized reporting table may be helpful to the radiologist and neurologist.

Archival and Storage:
Copies of these MRI studies should be retained permanently and be available. They should be stored in a standard format (example DICOM). It may be useful for patients to keep their own studies on portable digital media.
About this page
MedHelp Health Answers
MRI Gadolinium
FDA Gadolinium
MRI with contrast
Gadolinium side effects
GE Gadolinium
allergic reaction to contrast
MRI Contrast Dye
Gadolinium reactions